We conduct research on personalized stem cell therapies for patients with macular degeneration and retinitis pigmentosa.

The Retina: The “Film” Inside the Eye and the Core Neural Tissue for Vision
Degeneration of the macula,
the central part of the retina.
By replacing damaged macular cells with healthy cells,
we aim to preserve and restore vision.
[Cell Replacement Therapy Research]


A condition where retinal microvessels
are damaged due to diabetes.
By preventing damage to retinal microvessels and suppressing inflammation, we aim to regenerate retinal tissue.
[Vascular Regeneration & Inflammation Control Therapy Research]
A genetic disorder characterized by the degeneration of rod photoreceptor cells responsible for detecting light.
Through gene correction, we aim to treat the root cause of the disease and restore light-sensing function.
[Genetic Correction & Photoreceptor Regeneration Research]

We are developing innovative solutions to restore damaged retinal function through the transplantation of retinal pigment epithelial (RPE) cells differentiated from induced pluripotent stem cells (iPSCs).
Patient-derived blood
or skin cells are
collected to minimize
immune rejection.
Pluripotent stem cells
are produced through
reprogramming technology,
providing a stable source
for treatment.
High-purity retinal cells
are induced using
advanced differentiation
protocols.
Cells are safely
transplanted into the
subretinal space within
approved advanced
medical facilities.
As an officially approved institution for advanced regenerative medicine clinical research,
we conduct all studies safely under validated protocols.